India's critical care ventilator market to grow 4% CAGR by 2033 | Healthcare Asia Magazine
, India
Photo by Sandy Torchon via Pexels

India's critical care ventilator market to grow 4% CAGR by 2033

The country accounted for around 21% of the Asia-Pacific critical care ventilator market in 2023.

India's critical care ventilator market is set to experience a 4% compound annual growth rate (CAGR) from 2023 to 2033 due to the rising prevalence of chronic respiratory diseases, according to a GlobalData report. 

The surge of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma was exacerbated by factors such as urbanisation and industrial expansion.

Kanchan Chauhan, medical devices analyst at GlobalData, noted the heightened demand for critical care services due to the COVID-19 pandemic and an ageing population. 

ALSO READ: India shifts to early-stage investments in biologics and genomics

The introduction of advanced respiratory solutions like the Servo-c mechanical ventilator by Swedish company Getinge, is set to enhance treatment efficacy and operational efficiency in hospitals across India.

“India's healthcare sector is undergoing a remarkable evolution driven by technological progress, particularly evident in critical care ventilators. The nation's proactive response to the rising prevalence of respiratory diseases and an ageing population underscores its commitment to innovation, safety and improving public health outcomes,” said Chauhan.
 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

NUHCS to start using breakthrough drug for rare lung condition
Winrevair, which treats hypertension from constricted lung arteries, costs  $3,700-$6,730
Healthcare
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.
Healthcare
Electronic health records with AI show promise
They are also at risk from backdoor attacks, data poisoning and unauthorised access.